Professor Seok-Geun Lee
Kyung Hee University
Republic of Korea
Recent advances in genomics, proteomics, and metabolomics are changing the way physicians and scientists approach the diagnosis and treatment of cancer. Increased knowledge of cancer diagnosis with more detailed stratification based on patient omics data helps to move the field of precision oncology forward. In addition, developing new anti-cancer drugs targeting genetic changes is another important part of precision oncology. In this context, this Special Issue aims to cover molecular-mechanism-based research for anticancer therapy. It welcomes original research, and review articles on the discovery of molecular targets or/and molecular mechanisms of any anti-cancer agents, including conventional chemotherapy, novel potential anti-cancer drug candidates, and their combinations with any other anti-cancer modalities.
Submission deadline: 28/12/2022